Immunogenicity and PK/PD Biomarkers Conference

July 4, 2012 6:23 AM

Informa Life Sciences is organizing the 16th annual Immunogenicity & PK/PD Biomarkers Conference in Berlin, Germany on 26-27 September 2012.

With the increasing number of next-generation products, including biosimilars, different immunogenicity strategies need to be put in place in order to carefully evaluate immunogenicity. In addition, there is an industry movement from traditional immunogenicity testing to more clinical drug evaluation and risk assessment which is being applied by more and more big pharma. Understanding their strategies and how these approaches can improve immunogenicity prediction is essential to ensure product safety and approval.

Informa announce the new focus on PK/PD analysis, which is becoming an increasingly integrated approach in immunogenicity assessment. 2012 Immunogenicity event provides the latest strategies being applied by leading biopharm companies and demonstrating new data.

For more information, the website of the conference is: http://www.informa-ls.com/event/immunogenicity12

Would you like to post an event on Biosimilar News?

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!